Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette Hansen

Showing results (31-40 of 37) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 37 results.
Annals of the Rheumatic Diseases|May 10, 2011
ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitorsSusanne Juhl Pedersen, Inge Juul Sørensen, Patrick Garnero, et al.
Annals of the Rheumatic Diseases|September 11, 2009
Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitorsSusanne Juhl Pedersen, Inge Juul Sørensen, Kay-Geert A Hermann, et al.
Arthritis and Rheumatism|December 1, 2011
Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnoverSusanne Juhl Pedersen, Inge Juul Sørensen, Robert G W Lambert, et al.
Rheumatology (Oxford, England)|September 1, 2018
Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in routine care - 2-year outcomes and predictorsCecilie Heegaard Brahe, Simon Krabbe, Mikkel Østergaard, et al.
RMD Open|December 22, 2022
Flare during tapering of biological DMARDs in patients with rheumatoid arthritis in routine care: characteristics and predictorsL Terslev, Mikkel Ostergaard, Stylianos Georgiadis, et al.
Science (New York, N.Y.)|March 3, 2012
Condition-dependent transcriptome reveals high-level regulatory architecture in Bacillus subtilisPierre Nicolas, Ulrike Mäder, Etienne Dervyn, et al.
Science (New York, N.Y.)|March 3, 2012
Global network reorganization during dynamic adaptations of Bacillus subtilis metabolismJoerg Martin Buescher, Wolfram Liebermeister, Matthieu Jules, et al.
Pageof 4

Showing results (31-40 of 37) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 37 results.
Annals of the Rheumatic Diseases|May 10, 2011
ASDAS, BASDAI and different treatment responses and their relation to biomarkers of inflammation, cartilage and bone turnover in patients with axial spondyloarthritis treated with TNFα inhibitorsSusanne Juhl Pedersen, Inge Juul Sørensen, Patrick Garnero, et al.
Annals of the Rheumatic Diseases|September 11, 2009
Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitorsSusanne Juhl Pedersen, Inge Juul Sørensen, Kay-Geert A Hermann, et al.
Arthritis and Rheumatism|December 1, 2011
Radiographic progression is associated with resolution of systemic inflammation in patients with axial spondylarthritis treated with tumor necrosis factor α inhibitors: a study of radiographic progression, inflammation on magnetic resonance imaging, and circulating biomarkers of inflammation, angiogenesis, and cartilage and bone turnoverSusanne Juhl Pedersen, Inge Juul Sørensen, Robert G W Lambert, et al.
Rheumatology (Oxford, England)|September 1, 2018
Dose tapering and discontinuation of biological therapy in rheumatoid arthritis patients in routine care - 2-year outcomes and predictorsCecilie Heegaard Brahe, Simon Krabbe, Mikkel Østergaard, et al.
RMD Open|December 22, 2022
Flare during tapering of biological DMARDs in patients with rheumatoid arthritis in routine care: characteristics and predictorsL Terslev, Mikkel Ostergaard, Stylianos Georgiadis, et al.
Science (New York, N.Y.)|March 3, 2012
Condition-dependent transcriptome reveals high-level regulatory architecture in Bacillus subtilisPierre Nicolas, Ulrike Mäder, Etienne Dervyn, et al.
Science (New York, N.Y.)|March 3, 2012
Global network reorganization during dynamic adaptations of Bacillus subtilis metabolismJoerg Martin Buescher, Wolfram Liebermeister, Matthieu Jules, et al.
Pageof 4